WO1999039001A2 - Nucleic acid analysis method - Google Patents
Nucleic acid analysis method Download PDFInfo
- Publication number
- WO1999039001A2 WO1999039001A2 PCT/EP1999/000918 EP9900918W WO9939001A2 WO 1999039001 A2 WO1999039001 A2 WO 1999039001A2 EP 9900918 W EP9900918 W EP 9900918W WO 9939001 A2 WO9939001 A2 WO 9939001A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nucleic acid
- primer
- array
- sequence
- probe
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Definitions
- This invention concerns the characterisation, classification, identification and typing of different DNA containing organisms such as plants, animals, bacteria and their viruses.
- genomic polymorphisms The science of detecting genomic polymorphisms is quickly evolving, and several techniques have been developed to compare the genomes of different organisms. These techniques utilise the whole genome or segments thereof for comparison purposes and are often referred to as DNA fingerprinting techniques.
- DNA fingerprinting techniques The main application fields for these techniques are gene mapping, detection of bacterial strain diversity, population analysis, epidemiology, gene expression and the demonstration of phylogenetic and taxonomic relationships.
- ribosomes are present in all living organisms, and the ribosomes contain three kinds of rRNA (in bacteria 5 S, 16 S, and 23 S), DNA sequencing of the corresponding genes is frequently used for characterisation, identification and taxonomy relations of bacteria, fungi and other organisms.
- the most widely used of the ribosomal genes is 16 S rDNA.
- the DNA sequences of these genes contain well-defined segments of different evolutionary variability regions, which in the 16 S rRNA molecule are referred to as universal, semi-conserved and variable regions.
- Oligonucleotide primers complementary to universal regions can be used for amplification of ribosomal RNA from any organism or bacteria, the generated ribosomal fragment being then sequenced. In a computer search against a database with all known ribosomal sequences the species can be assigned.
- Random amplified polymorphic DNA is a process for detecting polymorphisms on the basis of nucleotide differences and is covered by US patent 5,126,239 of Livak et al, 1992.
- RAPD analysis is one of the most sensitive, reproducible and efficient methods currently available in the research field for distinguishing different strains and isolates of a species.
- RAPD analysis is a technique that uses a single short oligonucleotide primer of arbitrary sequence in a low stringency amplTfication reaction (Welsh J and McClelland M, 1990, Nucleic Acids Research, 18 (24), 7213-7218; Williams J G et a/ (1990) Nucleic Acids Research, 18, 6531-6535).
- the generated DNA fragments are subsequently analysed by gel electrophoresis. Analysis can either be done automatically on line with an automated DNA sequencer or on any electrophoresis gel and stained with ethidium bromide or silver.
- primers which have hybridised with a template, having a free 3 ' -end and having a free hydroxyl group can be extended with free dNTPs and a DNA polymerase. If ddNTPs or other chain terminators are added to the mixture the elongation will terminate at that point.
- a similar method to this was developed for mutation detection (WO 91/13075). The authors used a PCR template bound to wells of a microtitre plate, and the primers were added for extension after binding to the template. Further development of this method was carried out where consecutive primers overlapping each other by one base were bound to a support in the form of an array (also called a DNA chip).
- the present invention combines features of random amplified polymorphic DNA (RAPD) and of arrayed primer extension (APEX), techniques, so as to avoid the difficulty and delay of gel electrophoresis.
- the invention provides a nucleic acid analysis method which comprises:- a) using a primer to amplify the nucleic acid, b) providing an array of probes in which each probe comprises a primer sequence that is identical to (or complementary to) the sequence of the primer, and an adjacent sequence which is different in each probe of the array, c) applying the amplified nucleic acid from a) under hybridisation conditions to the array of b), d) effecting enzymatic chain extension of any probe where the adjacent sequence matches that of the hybridised amplified nucleic acid, and e) observing the location of probes of the array where chain extension has taken place in d).
- the nucleic acid to be analysed may be genomic DNA or RNA e.g. mRNA of an organism such as a plant, animal, bacteria or virus.
- the method is expected to be useful for applications where RAPD analysis is currently used, including gene mapping, detection of strain diversity, population analysis, epidemiology, the demonstration of phylogenetic and taxonomic relationships, and gene expression studies.
- the nucleic acid to be analysed is amplified using a single primer (or possibly several primers) in a low stringency amplification reaction e.g. by PCR.
- This primer is a chain of units capable of hybridising in a substantially sequence-specific manner to a suitable chain of the nucleic acid to be analysed; to form a hybrid in which the primer chain is capable of enzymatic chain extension.
- the primer is composed of units which are either nucleotides or nucleotide analogues.
- a nucleotide analogue is a compound which is capable of being incorporated in a chain of nucleotide residues; and which is capable of hybridising in a more or less base-specific manner with a base of a complementary nucleic acid chain; and which may be a substrate for chain-extending enzymes.
- a nucleotide analogue may be a nucleotide modified: in the base, e.g. so as to affect base-pairing properties; and/or in the sugar or backbone moiety, e.g. as in ddNTPs and in the amide linked backbones of PNA; and/or in the phosphate moiety.
- peptide nucleic acids are of interest.
- the primer is an oligonucleotide.
- the primer preferably has from 7 - 40 residues. Usually a short primer with 8 -10 residues is used, but primers with up to 20 or 40 residues are also possible. After amplification, all amplimers will have the same sequence at both ends, the length of that sequence depending on the primer.
- RTG RAPD beads marketed by Amersham Pharmacia Biotech which provide the reagents for the reactions.
- the RTG RAPD beads contain thermostable polymerases, dNTPs, BSA and buffer for a 25 ⁇ i reaction.
- the amplified nucleic acid is broken into fragments. Fragmentation is preferred because only small fragments may have access to a probe bound on a solid support.
- restriction enzymes and the enzyme uracil- DNA-glycosylase (UDGase).
- UDGase uracil- DNA-glycosylase
- dUTP To use UDGase, dUTP must be added to the amplification mix. UDGase activity is blocked by a UDGase inhibitor.
- Other enzymatic, chemical and physical methods of breaking the amplified nucleic acid are known and may be used.
- An important feature of this invention is the use of an array of immobilised probes. These are herein called probes, although they also act as primers for chain extension.
- Each immobilised probe comprises a primer sequence that is identical to (or complementary to) the sequence of the primer used in a).
- Each probe also comprises an adjacent sequence, generally of 1 - 8 nucleotide (or nucleotide analogue) residues.
- the adjacent sequence of each probe of the array is different from that of every other probe of the array.
- the array consists of a complete set of probes having adjacent sequences of a particular length, that is to say: four probes where each adjacent sequence is 1 nucleotide residue; or 16 probes where each adjacent sequence is 2 nucleotide residues; or 64 probes where each adjacent sequence is 3 nucleotide residues; or 4 n probes where each adjacent sequence is n nucleotide residues.
- the adjacent sequence is positioned at the 3'-end of the primer sequence of the probe.
- the probe is tethered to a support through the 5'-terminal residue of the primer sequence, either covalently or by means of strong binding agents such as the streptavidin- biotin system.
- step c) the fragments of the amplified nucleic acid from a) are applied under hybridisation conditions to the array. Because all probes of the array include a primer sequence complementary to the primer- derived sequence of the amplified nucleic acid, hybridisation takes place at every probe location of the array.
- step d) template-directed chain extension of probes of the array is effected.
- this chain extension is performed using a polymerase enzyme together with a supply of nucleotides or nucleotide analogues. Under these circumstances, chain extension only takes place where the nucleotide residues at the 3'-end of the probe accurately match those of the hybridised nucleic acid fragment.
- a nucleotide analogue may have a base analogue that is degenerate, by having the ability to base pair with two or three of the natural bases, or universal, by forming base pairs with each of the natural bases without discrimination.
- chain-terminating ddNTPs may be used as nucleotide analogues, and are preferred.
- Nucleotides or nucleotide analogues for addition during the chain extension step may be labelled for ease of detection.
- the nature of the label is not material to the invention. Examples are radioisotopes, fluorescent moieties, haptens, and components of chromogenic or chemiluminescent enzyme systems.
- the four ddNTPs are used, each labelled with a different fluorescent or other label, so that the four different signals can be read simultaneously.
- Step e) of the method involves observing the location of probes of the array when chain extension has taken place in d). This observation can be made by standard means using the one or more labels added during chain extension. The result is a pattern which is characteristic of the nucleic acid being analysed.
- the invention provides a nucleic acid analysis kit comprising: i) a primer for amplifying a nucleic acid, ii) an array of probes in which each probe comprises a primer sequence that is identical to (or complementary to) the sequence of the primer, and an adjacent sequence which is different in each probe of the array, iii) and reagents for effecting enzymatic chain extension of nucleic acid hybrids. Description of the ordered arrangement of an array of oligonucleotide probes.
- oligonucleotide primer typically has 7 to 40 nucleotides; for example with 10 nucleotides: 5'-NNNNNNNN-3'-OH.
- Oligonucleotide probes generally comprise oligonucleotide primers and an additional 1-8 bases; for example with 2 additional bases a total of 16 (4 2 ) probes are needed:
- FIG. 1 illustrates the principle of the invention.
- a template DNA fragment has a 10-mer oligonucleotide primer at its 3' end.
- An oligonucleotide probe has been immobilised on a surface of a support through a T ⁇ 2 anchor joined at the 5'-end of (the complement of) the 10-mer oligonucleotide primer sequence.
- the oligonucleotide probe carries at its 3'-end a random 3-mer extension, in this case TCA.
- the template DNA fragment has hybridised to the oligonucleotide probe.
- AGT sequence of the template DNA
- N nucleotides
- * labelled nucleotide analogues
- Figure 2 is a corresponding diagram showing an array of oligonucleotide probes, together with three fragments of template DNA where hybridisation and chain extension have taken place.
- Figure 3 shows bacterial genotyping data obtained in
- Example 1 on two different strains of E. coli using three different primers.
- Figure 4 shows TIRF data obtained on six different strains of Listeria in Example 3.
- the upper four panels show images obtained with four different labelled ddNTPs; and the lower panels show the data expressed graphically (capital letters are strong signals, lower case letters are weak signals).
- Figure 5 comprises four dendograms and contains a comparison between strong and weak assigned spots from the images.
- Primer 2 was compared with primer 6 amplified Listeria DNA in combination with two polymerase enzymes.
- RAPX is used to denote the method of the present invention comprising a combination of the random amplified polymorphic DNA (RAPD) and arrayed primer extension (APEX) techniques.
- RAPD random amplified polymorphic DNA
- APEX arrayed primer extension
- the first example shows the invention method performed in microtitre plates (MTP) with both fluorescein labelled dCTP and anti- fluorescein antibodies and detected by using para-nitrophenyl phosphate (pNpp). Two different bacterial DNA were used in order to show that different patterns could be generated.
- MTP microtitre plates
- pNpp para-nitrophenyl phosphate
- the second example shows the method performed on a microscope slide with one of the bacterial DNA as template.
- Genomic DNA was purified from E.coli strains according to standard protocols. Test DNA from Pharmacia Biotech RTGTM RAPD kit was used.
- Each DNA was amplified generally according to the manufacturer's protocol and with the RTG RAPD beads.
- One reaction contained 25 pmol primer, 10 ng bacterial DNA and water to 25 ⁇ l.
- Escherichia coli strains BL21 and C1a
- the generated RAPD products were fragmented according to two different methods, restriction enzyme cleavage or using the enzyme UDGase.
- the RAPD product (DNA) was cleaved with Alu1 and Hha1.
- One RAPD reaction contained 25 pmol primer, 10 ng bacterial DNA, 80 mM dUTP (Pharmacia Biotech), water to 25 ⁇ l and one RTG RAPD bead, with the same amplification conditions as above.
- Cleaved RAPD products were concentrated with a Centricon- 10 Concentrator.
- the concentrated DNA was then filtered through an Amicon EZ filter to remove excess of primers, free nucleotides and enzymes.
- DNA concentration was measured using Optical Density at 260nm and 280nm using spectrophotometer and calculate the volume to get 2.5 ⁇ g DNA for the hybridisation and extension reactions.
- RAPD DNA template (2.5 ⁇ g) was added to each well and heated to boiling temperature for 3 minutes.
- Tba Polymerase is a DNA polymerase from the bacterium Thermococcus barrossi.
- the yellow signal output read from each well is a quantitative measure on the amount of the RAPD fragment for that particular RAPD- extended probe. All data from the reader (Spectra Max 3000) was used for generation of a graph for each organism, Figure 3.
- Example 2 This experiment was performed to show that the method of the invention also works when the array of oligonucleotide probes is on a glass surface.
- Nucleic acid template material was prepared, as described in Example 1 , starting from genomic DNA of the E.coli strain BL21. Template material was validated by running samples on polyacrylamide gel and staining with ethidium bromide. It was found that the material digested with the mixture of frequent cutting enzymes (Alu1 and Hha1) seem to average about 250 bp in size (50 - 500 bp range). Hybridisation and extension reactions were performed generally as described in Example 1.
- the extension reaction mix was: 13.5 ⁇ l RAPD DNA fragments (2 pmol) 1 ⁇ l 17.5x Thermosequenase DNA polymerase buffer 1 ⁇ l unlabelled dNTPs (50 mM) 1 ⁇ l Cy5-ddCTP (50 mM)
- Template nucleic acid material (prepared as described in Example 1) that represents sequence information of the bacterial genome BL21 was then applied to the oligonucleotide probe array. Using a total internal reflection detection system, a specific pattern of signals was seen for template material from the BL21 source.
- E. coli BL21 and E. coli C1a strains are from the Amersham Pharmacia Biotech RTG RAPD kit.
- Six Listeria monocytogenes strains are Listeria monocytogenes; serotype 1 , serotype 2, serotype 4a, serotype 4b, ATCC 15313 and ATCC 35152.
- Primer 2 are from the Amersham Pharmacia Biotech RTG RAPD kit and primer 1283 is from Berg et al.
- Amplification reagents RAPD RTG beads from the
- N- ⁇ -3 is A, C, G or T.
- P CCCGT CAGCA
- P GCGAT CCCCA
- Cy2, Cy3 and Cy5 are pre-labelled primers with respectively dye. ( Can also be self extended in some cases.)
- Cy5 - ddUTP (often written as T in many of the reactions and results) 50 ⁇ M Dye mixes may vary from time to time, use normal stocks of 50 ⁇ M.
- ThermoSequenase DNA polymerase buffer 260 mM Tris-HCI pH 9.5; 65 mM MgCI 2 , this buffer does not have high influence on the APEX reaction.
- T.S. dilution buffer 10 mM Tris-HCI pH 8.0; 1 mM ⁇ -mercaptoethanol, 0.5% Tween-20 (v/v), 0.5% Nonidet P-40 (v/v)).
- KlenTaq X DNA polymerase (WO 92/06188 with the same mutation for improved ddNTP incorporation as in ThermoSequenase DNA polymerase) ⁇ 5 U/ ⁇ l.
- Preparation of glass slides before spotting of primer 1. Arrange 25-30 cover slips (24 x 60 mm) in a stainless staining tray.
- the RAPD amplification were done according to the Ready-To-Go RAPD instruction. After 45 cycles (96 °C, 1 min.; 36 °C,
- RAPX reactions set up: 1. 4 - 5 ⁇ l DNA from RAPD reaction (or from PCR reaction if an
- APEX slide has been used). Note that the DNA must be fragmented before this step.
- each reaction needs 20 ⁇ l, but the dry-down method is preferred, where all 40 ⁇ l of the reaction is physically spread out over the primer array with help of the tip of a pipette tip.
- the detection system is a total internal reflection fluorescence (TIRF) , where microscopic slides are placed on top of a prism with oil on to link a laser beam in to the glass slide.
- TIRF total internal reflection fluorescence
- the system has five different wave lengths from five different lasers to vary between. In this experiment only three were used.
- Image related software was based on Image Pro Plus 3.0. Results
- the RAPD amplification was done with RTG RAPD beads in order to use a standardised method for further high reproducibility.
- the amplified products were analysed on an ethidium bromide stained polyacrylamide gel.
- the only reference to compare with was the RAPD manual from APB with the different primers and the two E. coli stains. The expected bands were seen, and correspond very well. In summary, all DNA were nicely amplified except the Listeria DNA with primer 1283, which contained too much broken DNA.
- DNA from the two E. coli stains BL21 and C1 a were amplified and fragmented.
- the extension reaction is quick to set up and analyse.
- the extension can be done in two ways, either with or without a cover slip. If a cover slip is used the background is lower and was mainly used in the typing reactions, see below. But, in the first set up, the dry down method with no cover slip was used, which resulted in some circular shaped background.
- positive controls were used, in each corner of the matrix a mix of primers were added that always will be extended if the DNA polymerase is active. Below the matrix self extendible primers for the different bases were placed together with Cy-dyed primers for laser control.
- a self extended primer is a primer that has complementarily to it self or a neighbour, which then can be extended. The neighbour is seen in the cases with the 64 primers and the other control primers are fold back self extenders.
- the different pre-labelled primers gave expected signals showing that the detector and the imaging system is working. Taken together this show that the DNA polymerase is active and that the system is working perfectly with all positive signals.
- RAPD amplification and fragmentation the two E. coli stains BL21 and C1 were analysed on Primer 2 RAPX chips.
- the two different E. coli strains show clearly two different patterns, accordingly these two E. coli strains can be separated. Both E. coli strains gave four bands after RAPD analysis on PAA.
- Each band has two ends with the sequence from the primer, the sequence further in is not known. Accordingly, totally 8 spots can light up on a RAPX chip. Three panels with E. coli DNA have about 13 stronger signals and the control with no DNA has five signals, this corresponds well with the expected 8 spots. The position of the spots can not be predicted unless each fragment is sequenced or the whole genome of the organism is sequenced.
- the next step was to test if different patterns can be generated from several different strains, six strains from Listeria monocytogenes were then selected. The chosen strains had been typed with RAPD and analysed on silver stained gels by C. Ko, Hoefer see below, which will make it easier to interpret the results from the RAPX analysis. Before the typing started the following two tests were done, firstly check of primer chips for self-extendible primers. Secondly, test two different thermostable enzymes, ThermoSequenase DNA polymerase and KlenTaqX DNA polymerase. The comparison of different Listeria strains was finally done. During the work two different thermostable DNA polymerases was used.
- the RAPX method is shown to be a quick and accurate method. It takes approximately 30 minutes to perform the extension, and detection including hands on time and incubations. Different strains can be analysed with the RAPX method and the same cluster/groups can be identified when compared with ordinary gel electrophoresis. The speed and the easiness of the RAPX method guarantee for the future use of this array technology in bacterial typing as well as relationship studies of other organisms. An array format like this method could easily be highly automated.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99911663A EP1051523A2 (en) | 1998-02-02 | 1999-02-02 | Nucleic acid analysis method |
AU30276/99A AU3027699A (en) | 1998-02-02 | 1999-02-02 | Nucleic acid analysis method |
US09/601,258 US6280954B1 (en) | 1998-02-02 | 1999-02-02 | Arrayed primer extension technique for nucleic acid analysis |
JP2000529458A JP2002501760A (en) | 1998-02-02 | 1999-02-02 | Nucleic acid analysis method |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98300741.0 | 1998-02-02 | ||
EP98300741 | 1998-02-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1999039001A2 true WO1999039001A2 (en) | 1999-08-05 |
WO1999039001A3 WO1999039001A3 (en) | 1999-10-07 |
Family
ID=8234645
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/000918 WO1999039001A2 (en) | 1998-02-02 | 1999-02-02 | Nucleic acid analysis method |
Country Status (5)
Country | Link |
---|---|
US (1) | US6280954B1 (en) |
EP (1) | EP1051523A2 (en) |
JP (1) | JP2002501760A (en) |
AU (1) | AU3027699A (en) |
WO (1) | WO1999039001A2 (en) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001025485A2 (en) * | 1999-10-06 | 2001-04-12 | Amersham Biosciences Corp | Method for detecting mutations using arrayed primer extension |
WO2001036679A2 (en) * | 1999-11-15 | 2001-05-25 | Hartwell John G | METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS |
WO2001036681A2 (en) * | 1999-11-15 | 2001-05-25 | Digene Corporation | Immunological detection of rna:dna hybrids on microarrays |
WO2001071041A2 (en) * | 2000-03-22 | 2001-09-27 | Mergen Ltd. | Microarray-based analysis of polynucleotide sequence variations |
WO2001083822A2 (en) * | 2000-05-01 | 2001-11-08 | Cold Spring Harbor Laboratory | Use of representations of dna for genetic analysis |
WO2002022870A2 (en) * | 2000-09-18 | 2002-03-21 | Eidgenössische Forschungsanstalt Für Obst-, Wein- Und Gartenbau | Method for the characterization and/or identification of genomes |
WO2001012862A3 (en) * | 1999-08-18 | 2002-05-02 | Illumina Inc | Compositions and methods for preparing oligonucleotide solutions |
EP1207209A2 (en) * | 2000-11-09 | 2002-05-22 | Agilent Technologies Inc. (a Delaware Corporation) | Methods using arrays for detection of single nucleotide polymorphisms |
WO2002059357A2 (en) * | 2001-01-24 | 2002-08-01 | Genomic Expression Aps | Assay and kit for analyzing gene expression |
EP1234058A2 (en) * | 1999-11-26 | 2002-08-28 | Curagen Corporation | Nucleic acid probe arrays |
US6544732B1 (en) | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
EP1341933A2 (en) * | 2000-10-20 | 2003-09-10 | The Board of Regents of the Leland Stanford Junior University | Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
EP1390545A1 (en) * | 2001-04-24 | 2004-02-25 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
EP1390546A2 (en) * | 2001-04-24 | 2004-02-25 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
US6812005B2 (en) | 2000-02-07 | 2004-11-02 | The Regents Of The University Of California | Nucleic acid detection methods using universal priming |
WO2007100637A2 (en) * | 2006-02-22 | 2007-09-07 | Helicos Biosciences Corporation | Methods for mutation detection |
US7285384B2 (en) | 2000-02-16 | 2007-10-23 | Illuminia, Inc. | Parallel genotyping of multiple patient samples |
US7399589B2 (en) | 1998-02-06 | 2008-07-15 | Digene Corporation | Immunological detection of RNA:DNA hybrids on microarrays |
US7439016B1 (en) | 2000-06-15 | 2008-10-21 | Digene Corporation | Detection of nucleic acids by type-specific hybrid capture method |
US7501245B2 (en) | 1999-06-28 | 2009-03-10 | Helicos Biosciences Corp. | Methods and apparatuses for analyzing polynucleotide sequences |
US7531307B2 (en) | 1997-10-30 | 2009-05-12 | Cold Spring Harbor Laboratory | Use of representations of DNA for genetic analysis |
US7601497B2 (en) | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
US7645596B2 (en) | 1998-05-01 | 2010-01-12 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
US7887752B2 (en) | 2003-01-21 | 2011-02-15 | Illumina, Inc. | Chemical reaction monitor |
US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
US8694263B2 (en) | 2003-05-23 | 2014-04-08 | Cold Spring Harbor Laboratory | Method of identifying virtual representations of nucleotide sequences |
WO2014118377A2 (en) * | 2013-02-01 | 2014-08-07 | Ozan Selvi | Primer technology |
US8877436B2 (en) | 2008-10-27 | 2014-11-04 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay on an automated platform |
US9096898B2 (en) | 1998-05-01 | 2015-08-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9605303B2 (en) | 2010-01-29 | 2017-03-28 | Qiagen Gaithersburg, Inc. | Method of determining and confirming the presence of an HPV in a sample |
US9657344B2 (en) | 2003-11-12 | 2017-05-23 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
US9689047B2 (en) | 2010-01-29 | 2017-06-27 | Qiagen Gaithersburg Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
US9850536B2 (en) | 2000-02-07 | 2017-12-26 | Illumina, Inc. | Multiplex nucleic acid reactions |
US9885092B2 (en) | 2011-02-24 | 2018-02-06 | Qiagen Gaithersburg Inc. | Materials and methods for detection of HPV nucleic acids |
Families Citing this family (49)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7060431B2 (en) | 1998-06-24 | 2006-06-13 | Illumina, Inc. | Method of making and decoding of array sensors with microspheres |
US20060275782A1 (en) | 1999-04-20 | 2006-12-07 | Illumina, Inc. | Detection of nucleic acid reactions on bead arrays |
US8481268B2 (en) | 1999-05-21 | 2013-07-09 | Illumina, Inc. | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US20040038206A1 (en) * | 2001-03-14 | 2004-02-26 | Jia Zhang | Method for high throughput assay of genetic analysis |
US20030036073A1 (en) * | 2001-06-07 | 2003-02-20 | Saba James Anthony | Matrix Sequencing: a novel method of polynucleotide analysis utilizing probes containing universal nucleotides |
US9261460B2 (en) | 2002-03-12 | 2016-02-16 | Enzo Life Sciences, Inc. | Real-time nucleic acid detection processes and compositions |
US20040161741A1 (en) | 2001-06-30 | 2004-08-19 | Elazar Rabani | Novel compositions and processes for analyte detection, quantification and amplification |
US9777312B2 (en) * | 2001-06-30 | 2017-10-03 | Enzo Life Sciences, Inc. | Dual polarity analysis of nucleic acids |
US20030087298A1 (en) * | 2001-11-02 | 2003-05-08 | Roland Green | Detection of hybridization on oligonucleotide microarray through covalently labeling microarray probe |
US20030170637A1 (en) * | 2002-03-06 | 2003-09-11 | Pirrung Michael C. | Method of analyzing mRNA splice variants |
US9353405B2 (en) | 2002-03-12 | 2016-05-31 | Enzo Life Sciences, Inc. | Optimized real time nucleic acid detection processes |
US20030186252A1 (en) * | 2002-04-01 | 2003-10-02 | Ilsley Diane D. | Array based hybridization assays employing enzymatically generated labeled target nucleic acids and compositions for practicing the same |
US20040259100A1 (en) * | 2003-06-20 | 2004-12-23 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
US20050053980A1 (en) | 2003-06-20 | 2005-03-10 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
US20050181394A1 (en) * | 2003-06-20 | 2005-08-18 | Illumina, Inc. | Methods and compositions for whole genome amplification and genotyping |
WO2005006951A2 (en) * | 2003-07-10 | 2005-01-27 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for determining whether a subject carries a cystic fibrosis transmembrane conductance regulator (cftr) gene mutation |
US20050153320A1 (en) * | 2003-11-06 | 2005-07-14 | Herron James N. | Single base extension |
US20070264636A1 (en) * | 2005-05-02 | 2007-11-15 | The Board Of Trustees Of The Leland Stanford Junior University | Capture and random amplification protocol for identification and monitoring of microbial diversity |
US20100216147A1 (en) * | 2009-01-28 | 2010-08-26 | Qiagen Gaithersburg, Inc. | Sequence-specific large volume sample preparation method and assay |
JP5730280B2 (en) | 2009-03-16 | 2015-06-03 | パング バイオファーマ リミテッド | Compositions and methods comprising histidyl-tRNA synthetase splice variants having non-canonical biological activity |
JP5848236B2 (en) | 2009-03-31 | 2016-01-27 | エータイアー ファーマ, インコーポレイテッド | Compositions and methods comprising aspartyl tRNA synthetase with non-standard biological activity |
CA2760542A1 (en) | 2009-05-01 | 2010-11-04 | Qiagen Gaithersburg, Inc. | A non-target amplification method for detection of rna splice-forms in a sample |
JP5765841B2 (en) * | 2009-05-27 | 2015-08-19 | 富士フイルム株式会社 | Nucleic acid microarray quality inspection method |
JP5826752B2 (en) | 2009-09-14 | 2015-12-02 | キアジェン ゲイサーズバーグ インコーポレイテッド | Compositions and methods for recovering nucleic acids or proteins from tissue samples fixed in cytological media |
CA2797093C (en) | 2010-04-26 | 2019-10-29 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of cysteinyl-trna synthetase |
CN103096911B (en) | 2010-04-27 | 2018-05-29 | Atyr 医药公司 | Treatment relevant with the protein fragments of Isoleucyl-tRNA synthetase, diagnosis and the innovation of antibody compositions are found |
JP6008837B2 (en) | 2010-04-28 | 2016-10-19 | エータイアー ファーマ, インコーポレイテッド | Innovative discovery of therapeutic, diagnostic and antibody compositions related to protein fragments of alanyl tRNA synthetase |
AU2011248490B2 (en) | 2010-04-29 | 2016-11-10 | Pangu Biopharma Limited | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Asparaginyl tRNA synthetases |
US9068177B2 (en) | 2010-04-29 | 2015-06-30 | Atyr Pharma, Inc | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases |
CA2797393C (en) | 2010-04-29 | 2020-03-10 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of valyl trna synthetases |
AU2011246976B2 (en) | 2010-04-29 | 2016-01-28 | Allarity Therapeutics Europe ApS | Methods and devices for predicting treatment efficacy |
CN103096912A (en) | 2010-05-03 | 2013-05-08 | Atyr医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases |
CA2797277C (en) | 2010-05-03 | 2021-02-23 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of arginyl-trna synthetases |
CA2797978C (en) | 2010-05-03 | 2019-12-03 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-trna synthetases |
AU2011248101B2 (en) | 2010-05-04 | 2016-10-20 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of p38 multi-tRNA synthetase complex |
CN103200953B (en) | 2010-05-14 | 2017-02-15 | Atyr 医药公司 | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases |
US9034598B2 (en) | 2010-05-17 | 2015-05-19 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of leucyl-tRNA synthetases |
CA2799200A1 (en) | 2010-05-19 | 2011-11-24 | Qiagen Gaithersburg, Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
WO2011153277A2 (en) | 2010-06-01 | 2011-12-08 | Atyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of lysyl-trna synthetases |
EP2593125B1 (en) | 2010-07-12 | 2017-11-01 | aTyr Pharma, Inc. | Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases |
EP2608801B1 (en) | 2010-08-25 | 2019-08-21 | aTyr Pharma, Inc. | INNOVATIVE DISCOVERY OF THERAPEUTIC, DIAGNOSTIC, AND ANTIBODY COMPOSITIONS RELATED TO PROTEIN FRAGMENTS OF TYROSYL-tRNA SYNTHETASES |
CN103930563B (en) | 2011-06-01 | 2016-11-09 | 医学预后研究所 | For the method and apparatus predicting cancer return |
MX356107B (en) | 2012-02-16 | 2018-05-15 | Atyr Pharma Inc | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases. |
CA2892822C (en) | 2012-11-27 | 2023-08-08 | Pontificia Universidad Catolica De Chile | Compositions and methods for diagnosing thyroid tumors |
US10392667B2 (en) | 2013-06-07 | 2019-08-27 | Medical Prognosis Institute A/S | Methods and devices for predicting treatment efficacy of fulvestrant in cancer patients |
WO2016008048A1 (en) | 2014-07-15 | 2016-01-21 | Ontario Institute For Cancer Research | Methods and devices for predicting anthracycline treatment efficacy |
CN110249059B (en) | 2017-01-20 | 2021-04-13 | 欧姆尼欧美公司 | Allele-specific capture of nucleic acids |
US9932631B1 (en) | 2017-09-11 | 2018-04-03 | Omniome, Inc. | Genotyping by polymerase binding |
EA202091168A1 (en) | 2017-12-28 | 2020-11-24 | Бореалис Аг | CATALYST AND ITS PRODUCTION |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991005060A2 (en) * | 1989-09-29 | 1991-04-18 | Applied Biosystems, Inc. | Spectrally resolvable rhodamine dyes for nucleic acid sequence determination |
WO1991014001A2 (en) * | 1990-03-14 | 1991-09-19 | E.I. Du Pont De Nemours And Company | A process for distinguishing nucleic acids on the basis of nucleotide differences |
EP0534858A1 (en) * | 1991-09-24 | 1993-03-31 | Keygene N.V. | Selective restriction fragment amplification : a general method for DNA fingerprinting |
WO1993017126A1 (en) * | 1992-02-19 | 1993-09-02 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
EP0630972A2 (en) * | 1993-06-25 | 1994-12-28 | Hitachi, Ltd. | DNA analyzing method |
EP0649852A1 (en) * | 1993-10-26 | 1995-04-26 | Hitachi, Ltd. | Fractionation method for nucleotide fragments |
EP0701001A2 (en) * | 1994-09-07 | 1996-03-13 | Hitachi, Ltd. | DNA separating, fractionating and analyzing method and system therefor |
WO1996041893A1 (en) * | 1995-06-09 | 1996-12-27 | The University Of Tennessee Research Corporation | Methods for the generation of sequence signatures from nucleic acids |
WO1997022720A1 (en) * | 1995-12-21 | 1997-06-26 | Kenneth Loren Beattie | Arbitrary sequence oligonucleotide fingerprinting |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6004744A (en) * | 1991-03-05 | 1999-12-21 | Molecular Tool, Inc. | Method for determining nucleotide identity through extension of immobilized primer |
US5981176A (en) * | 1992-06-17 | 1999-11-09 | City Of Hope | Method of detecting and discriminating between nucleic acid sequences |
US5503980A (en) * | 1992-11-06 | 1996-04-02 | Trustees Of Boston University | Positional sequencing by hybridization |
-
1999
- 1999-02-02 US US09/601,258 patent/US6280954B1/en not_active Expired - Fee Related
- 1999-02-02 JP JP2000529458A patent/JP2002501760A/en active Pending
- 1999-02-02 EP EP99911663A patent/EP1051523A2/en not_active Withdrawn
- 1999-02-02 AU AU30276/99A patent/AU3027699A/en not_active Abandoned
- 1999-02-02 WO PCT/EP1999/000918 patent/WO1999039001A2/en not_active Application Discontinuation
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991005060A2 (en) * | 1989-09-29 | 1991-04-18 | Applied Biosystems, Inc. | Spectrally resolvable rhodamine dyes for nucleic acid sequence determination |
WO1991014001A2 (en) * | 1990-03-14 | 1991-09-19 | E.I. Du Pont De Nemours And Company | A process for distinguishing nucleic acids on the basis of nucleotide differences |
EP0534858A1 (en) * | 1991-09-24 | 1993-03-31 | Keygene N.V. | Selective restriction fragment amplification : a general method for DNA fingerprinting |
WO1993017126A1 (en) * | 1992-02-19 | 1993-09-02 | The Public Health Research Institute Of The City Of New York, Inc. | Novel oligonucleotide arrays and their use for sorting, isolating, sequencing, and manipulating nucleic acids |
EP0630972A2 (en) * | 1993-06-25 | 1994-12-28 | Hitachi, Ltd. | DNA analyzing method |
EP0649852A1 (en) * | 1993-10-26 | 1995-04-26 | Hitachi, Ltd. | Fractionation method for nucleotide fragments |
EP0701001A2 (en) * | 1994-09-07 | 1996-03-13 | Hitachi, Ltd. | DNA separating, fractionating and analyzing method and system therefor |
WO1996041893A1 (en) * | 1995-06-09 | 1996-12-27 | The University Of Tennessee Research Corporation | Methods for the generation of sequence signatures from nucleic acids |
WO1997022720A1 (en) * | 1995-12-21 | 1997-06-26 | Kenneth Loren Beattie | Arbitrary sequence oligonucleotide fingerprinting |
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7531307B2 (en) | 1997-10-30 | 2009-05-12 | Cold Spring Harbor Laboratory | Use of representations of DNA for genetic analysis |
US8663917B2 (en) | 1997-10-30 | 2014-03-04 | Cold Spring Harbor Laboratory | Use of representations of DNA for genetic analysis |
US7399589B2 (en) | 1998-02-06 | 2008-07-15 | Digene Corporation | Immunological detection of RNA:DNA hybrids on microarrays |
US6686151B1 (en) | 1998-02-06 | 2004-02-03 | Digene Corporation | Immunological detection of RNA:DNA hybrids on microarrays |
US10214774B2 (en) | 1998-05-01 | 2019-02-26 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9458500B2 (en) | 1998-05-01 | 2016-10-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9212393B2 (en) | 1998-05-01 | 2015-12-15 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US7645596B2 (en) | 1998-05-01 | 2010-01-12 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9096898B2 (en) | 1998-05-01 | 2015-08-04 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US10208341B2 (en) | 1998-05-01 | 2019-02-19 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9725764B2 (en) | 1998-05-01 | 2017-08-08 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US9957561B2 (en) | 1998-05-01 | 2018-05-01 | Life Technologies Corporation | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6890764B2 (en) | 1999-05-20 | 2005-05-10 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
US6544732B1 (en) | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
US7501245B2 (en) | 1999-06-28 | 2009-03-10 | Helicos Biosciences Corp. | Methods and apparatuses for analyzing polynucleotide sequences |
US7604996B1 (en) | 1999-08-18 | 2009-10-20 | Illumina, Inc. | Compositions and methods for preparing oligonucleotide solutions |
WO2001012862A3 (en) * | 1999-08-18 | 2002-05-02 | Illumina Inc | Compositions and methods for preparing oligonucleotide solutions |
US9745573B2 (en) | 1999-08-18 | 2017-08-29 | Illumina, Inc. | Compositions and methods for preparing oligonucleotide solutions |
WO2001025485A3 (en) * | 1999-10-06 | 2002-09-12 | Amersham Biosciences Corp | Method for detecting mutations using arrayed primer extension |
US6448010B1 (en) | 1999-10-06 | 2002-09-10 | Amersham Pharmacia Biotech, Inc. | Method for detecting mutations using arrayed primer extension |
WO2001025485A2 (en) * | 1999-10-06 | 2001-04-12 | Amersham Biosciences Corp | Method for detecting mutations using arrayed primer extension |
WO2001036681A3 (en) * | 1999-11-15 | 2001-12-13 | Digene Corp | Immunological detection of rna:dna hybrids on microarrays |
WO2001036679A3 (en) * | 1999-11-15 | 2001-11-22 | John G Hartwell | METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS |
WO2001036681A2 (en) * | 1999-11-15 | 2001-05-25 | Digene Corporation | Immunological detection of rna:dna hybrids on microarrays |
WO2001036679A2 (en) * | 1999-11-15 | 2001-05-25 | Hartwell John G | METHODS FOR GENERATING SINGLE STRANDED cDNA FRAGMENTS |
EP1234058A2 (en) * | 1999-11-26 | 2002-08-28 | Curagen Corporation | Nucleic acid probe arrays |
US9850536B2 (en) | 2000-02-07 | 2017-12-26 | Illumina, Inc. | Multiplex nucleic acid reactions |
US6812005B2 (en) | 2000-02-07 | 2004-11-02 | The Regents Of The University Of California | Nucleic acid detection methods using universal priming |
US10837059B2 (en) | 2000-02-07 | 2020-11-17 | Illumina, Inc. | Multiplex nucleic acid reactions |
US7803537B2 (en) | 2000-02-16 | 2010-09-28 | Illumina, Inc. | Parallel genotyping of multiple patient samples |
US7285384B2 (en) | 2000-02-16 | 2007-10-23 | Illuminia, Inc. | Parallel genotyping of multiple patient samples |
JP2003527867A (en) * | 2000-03-22 | 2003-09-24 | マージェン リミテッド | Microarray-based analysis of polynucleotide sequence alterations |
WO2001071041A3 (en) * | 2000-03-22 | 2002-07-18 | Mergen Ltd | Microarray-based analysis of polynucleotide sequence variations |
WO2001071041A2 (en) * | 2000-03-22 | 2001-09-27 | Mergen Ltd. | Microarray-based analysis of polynucleotide sequence variations |
WO2001083822A3 (en) * | 2000-05-01 | 2003-03-20 | Cold Spring Harbor Lab | Use of representations of dna for genetic analysis |
WO2001083822A2 (en) * | 2000-05-01 | 2001-11-08 | Cold Spring Harbor Laboratory | Use of representations of dna for genetic analysis |
US7439016B1 (en) | 2000-06-15 | 2008-10-21 | Digene Corporation | Detection of nucleic acids by type-specific hybrid capture method |
US7601497B2 (en) | 2000-06-15 | 2009-10-13 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
US7645571B2 (en) | 2000-06-15 | 2010-01-12 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by type-specific hybrid capture method |
WO2002022870A2 (en) * | 2000-09-18 | 2002-03-21 | Eidgenössische Forschungsanstalt Für Obst-, Wein- Und Gartenbau | Method for the characterization and/or identification of genomes |
WO2002022870A3 (en) * | 2000-09-18 | 2003-09-04 | Eidgenoessische Forschungsanst | Method for the characterization and/or identification of genomes |
US7223540B2 (en) | 2000-10-20 | 2007-05-29 | The Board Of Trustees Of The Leland Stanford Junior University | Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
EP1341933A4 (en) * | 2000-10-20 | 2005-02-16 | Univ Leland Stanford Junior | Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
EP1341933A2 (en) * | 2000-10-20 | 2003-09-10 | The Board of Regents of the Leland Stanford Junior University | Transient electrical signal based methods and devices for characterizing molecular interaction and/or motion in a sample |
EP1207209A2 (en) * | 2000-11-09 | 2002-05-22 | Agilent Technologies Inc. (a Delaware Corporation) | Methods using arrays for detection of single nucleotide polymorphisms |
EP1207209A3 (en) * | 2000-11-09 | 2002-09-11 | Agilent Technologies, Inc. (a Delaware corporation) | Methods using arrays for detection of single nucleotide polymorphisms |
WO2002059357A3 (en) * | 2001-01-24 | 2004-03-25 | Genomic Expression Aps | Assay and kit for analyzing gene expression |
WO2002059357A2 (en) * | 2001-01-24 | 2002-08-01 | Genomic Expression Aps | Assay and kit for analyzing gene expression |
EP1390546A4 (en) * | 2001-04-24 | 2004-06-23 | 3M Innovative Properties Co | Biological sample processing methods and compositions that include surfactants |
EP1390545A4 (en) * | 2001-04-24 | 2004-06-30 | 3M Innovative Properties Co | Biological sample processing methods and compositions that include surfactants |
EP1390545A1 (en) * | 2001-04-24 | 2004-02-25 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
EP1390546A2 (en) * | 2001-04-24 | 2004-02-25 | 3M Innovative Properties Company | Biological sample processing methods and compositions that include surfactants |
US8592214B2 (en) | 2003-01-21 | 2013-11-26 | Illumina, Inc. | Chemical reaction monitor |
US7887752B2 (en) | 2003-01-21 | 2011-02-15 | Illumina, Inc. | Chemical reaction monitor |
US8694263B2 (en) | 2003-05-23 | 2014-04-08 | Cold Spring Harbor Laboratory | Method of identifying virtual representations of nucleotide sequences |
US9657344B2 (en) | 2003-11-12 | 2017-05-23 | Fluidigm Corporation | Short cycle methods for sequencing polynucleotides |
US7981604B2 (en) | 2004-02-19 | 2011-07-19 | California Institute Of Technology | Methods and kits for analyzing polynucleotide sequences |
US9115410B2 (en) | 2004-10-20 | 2015-08-25 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
US8901287B2 (en) | 2004-10-20 | 2014-12-02 | Qiagen Gaithersburg, Inc. | Detection of nucleic acids by target-specific hybrid capture method |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
US9868978B2 (en) | 2005-08-26 | 2018-01-16 | Fluidigm Corporation | Single molecule sequencing of captured nucleic acids |
WO2007100637A3 (en) * | 2006-02-22 | 2007-11-15 | Helicos Biosciences Corp | Methods for mutation detection |
WO2007100637A2 (en) * | 2006-02-22 | 2007-09-07 | Helicos Biosciences Corporation | Methods for mutation detection |
US8877436B2 (en) | 2008-10-27 | 2014-11-04 | Qiagen Gaithersburg, Inc. | Fast results hybrid capture assay on an automated platform |
US9689047B2 (en) | 2010-01-29 | 2017-06-27 | Qiagen Gaithersburg Inc. | Methods and compositions for sequence-specific purification and multiplex analysis of nucleic acids |
US9605303B2 (en) | 2010-01-29 | 2017-03-28 | Qiagen Gaithersburg, Inc. | Method of determining and confirming the presence of an HPV in a sample |
US9885092B2 (en) | 2011-02-24 | 2018-02-06 | Qiagen Gaithersburg Inc. | Materials and methods for detection of HPV nucleic acids |
WO2014118377A2 (en) * | 2013-02-01 | 2014-08-07 | Ozan Selvi | Primer technology |
EP3633046A1 (en) * | 2013-02-01 | 2020-04-08 | Ozan Selvi | Primer technology |
WO2014118377A3 (en) * | 2013-02-01 | 2014-12-04 | Ozan Selvi | Primer technology |
Also Published As
Publication number | Publication date |
---|---|
AU3027699A (en) | 1999-08-16 |
JP2002501760A (en) | 2002-01-22 |
US6280954B1 (en) | 2001-08-28 |
EP1051523A2 (en) | 2000-11-15 |
WO1999039001A3 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6280954B1 (en) | Arrayed primer extension technique for nucleic acid analysis | |
US5650274A (en) | DNA analyzing method | |
EP1759011B1 (en) | Detection of chromosomal disorders | |
US6110709A (en) | Cleaved amplified modified polymorphic sequence detection methods | |
EP0907752B1 (en) | Method for determination of nucleic acid sequences and diagnostic applications thereof | |
US6258539B1 (en) | Restriction enzyme mediated adapter | |
EP0777747B1 (en) | Nucleotide sequencing method | |
EP1138782B1 (en) | Multiplex sequence variation analysis of DNA samples by mass spectrometry | |
US6004783A (en) | Cleaved amplified RFLP detection methods | |
US6248521B1 (en) | Amplification and other enzymatic reactions performed on nucleic acid arrays | |
CN1882703B (en) | Multiplexed nucleic acid analysis by fragmentation of double-stranded DNA | |
KR20020008195A (en) | Microarray-based analysis of polynucleotide sequence variations | |
WO1995021271A1 (en) | Ligase/polymerase-mediated genetic bit analysistm of single nucleotide polymorphisms and its use in genetic analysis | |
CA2497740A1 (en) | Multiplexed analysis of polymorphic loci by probe elongation-mediated detection | |
JP2010213709A (en) | Length determination of nucleic acid repeat sequences by discontinuous primer extension | |
CN110546273A (en) | quantification of NGS DNA by adaptor sequences | |
WO2003064692A1 (en) | Detecting and quantifying many target nucleic acids within a single sample | |
KR20030092136A (en) | Analytical method and kit | |
US20090136916A1 (en) | Methods and microarrays for detecting enteric viruses | |
JP3942079B2 (en) | Methods for exogenous control and internal control during nucleic acid amplification | |
WO2004050906A1 (en) | Methylation dna detecting method | |
US7001722B1 (en) | Parallel primer extension approach to nucleic acid sequence analysis | |
AU4669100A (en) | Nucleotide extension on a microarray of gel-immobilized primers | |
Lucas | The application of nucleic acid microarrays for the detection of genetically modified organisms | |
JP5378724B2 (en) | Expression mRNA identification method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
NENP | Non-entry into the national phase |
Ref country code: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1999911663 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09601258 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 1999911663 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999911663 Country of ref document: EP |